鸦胆子乳合GP方案治疗中晚期非小细胞肺癌  被引量:2

Curative Effect Observation of Brucea Javanica Oil Emulsion Combined with GP Chemotherapy on Treating Advanced Non-small Cell Lung Cancer

在线阅读下载全文

作  者:王廷祥[1] 舒琦瑾[1] 

机构地区:[1]浙江医院肿瘤科,杭州310007

出  处:《浙江中西医结合杂志》2007年第9期535-536,共2页Zhejiang Journal of Integrated Traditional Chinese and Western Medicine

摘  要:目的:观察鸦胆子乳剂注射液与GP方案化疗联合治疗晚期非小细胞肺癌的近期疗效及毒副反应。方法:将40例晚期非小细胞肺癌患者随机分两组,治疗组用鸦胆子乳剂+GP方案治疗(即泽菲加顺铂);对照组应用GP方案治疗。结果:治疗组有效率50%,对照组有效率45%,两组对比差异无显著意义(P<0.05);两组患者近期疗效差异无统计学意义;治疗组生活质量改善75%,对照组50%,治疗组明显优于对照组(P<0.01);消化道反应,治疗组Ⅰ、Ⅱ、Ⅲ度发生率30%,对照组50%,两组比较,差异有显著意义(P<0.01)。结论:鸦胆子乳剂注射液与GP方案联合治疗晚期非小细胞肺癌可明显提高患者的生活质量,改善症状,减轻化疗的毒副反应。Objective:To obverse the clinical curative effect and side effect of brucea Javanica oil emulsion (BJOE) combined with GP chemotherapy on treating advanced non-small cell lung cancer (NSCLC). Methods:40 cases of NSCLC were randomly divided into the treatment group and the contrast group. The treatment was treated by B JOE combined with GP chemotherapy and the contrast group by GP chemotherapy only. Results: The effective ratios of the treatment group and the contrast group were 50% and 45% respectively. The difference of two groups had no significant meaning (P 〈 0.05 ). The difference of curative effect had no statistical meaning. The ratio of improved life quality in the treatment group and the contrast group was 75% and 50%. The life quality of the treatment group was obviously improved than that in the contrast group ( P 〈 0.01 ). The ratio of enteron response with Ⅰ , Ⅱ and Ⅲ degree in the treatment group and the contrast group was 30% and 50%. The difference had significant meaning (P 〈0.01 ). Conclusion:BJOE has good curative effect on treating advanced NSCLC, especially enhances the life quality, improves symptom and decreases the side effect of chemotherapy.

关 键 词:非小细胞肺癌 鸦胆子乳剂 GP方案 疗效性 安全性 

分 类 号:R734.2[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象